title: Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson's disease.
authors.forename: P
authors.initials: P
authors.lastname: Limousin
authors.forename: P
authors.initials: P
authors.lastname: Pollak
authors.forename: C L
authors.initials: CL
authors.lastname: Gervason-Tournier
authors.forename: M
authors.initials: M
authors.lastname: Hommel
authors.forename: J E
authors.initials: JE
authors.lastname: Perret
mesh_terms: D000368:Aged; D001577:Benzophenones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D065098:Catechol O-Methyltransferase Inhibitors; D004311:Double-Blind Method; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D000077867:Tolcapone
chemical_list: D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D009596:Nitrophenols; D007980:Levodopa; D000077867:Tolcapone